Relmada Therapeutics Inc.

NASDAQ: RLMD · Real-Time Price · USD
0.63
0.02 (3.75%)
At close: Aug 15, 2025, 3:59 PM
0.65
1.88%
After-hours: Aug 15, 2025, 07:40 PM EDT

Relmada Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.86M 4.09M 5.4M 44.44M
Short-Term Investments
41.05M 92.23M 142.93M 167.47M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
21.98K 43.13K 34.88K 28.29K
Receivables
n/a n/a 512.43K 86.38K
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
45.8M 97.51M 152.87M 223.3M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
21.98K 43.13K 34.88K 28.29K
Total Assets
45.82M 97.55M 152.91M 223.33M
Account Payables
4.13M 3.51M 5.26M 11.19M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
1.15M 5.68M n/a n/a
Total Current Liabilities
10.29M 12.19M 12.47M 15.06M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
4.47K n/a 123.00 75.00
Total Long-Term Liabilities
4.47K n/a 123.00 75.00
Total Liabilities
10.3M 12.19M 12.47M 15.06M
Total Debt
n/a n/a n/a n/a
Common Stock
30.17K 30.1K 30.1K 27.74K
Retained Earnings
-640.88M -560.9M -462.11M -305.07M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
35.52M 85.36M 140.44M 208.26M
Total Investments
41.05M 92.23M 142.93M 167.47M